A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
An Almost Normal Life Expectancy for People With HIV?
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Misleading News Reports Suggest HIV Cure Is Near
New HIV Drug Class Shows Promise
Gene Therapy Shows Promise in Controlling HIV
Potential Microbicide Tricks HIV Into Sudden Death
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

February 8, 2011

New Cure-Related Research: Antabuse to Flush HIV Reservoir

A new clinical trial has just gotten underway to test the ability of Antabuse (disulfiram)—a drug used for years to treat alcoholism—to flush out the hidden reservoir of HIV that evades both the immune system and antiretroviral (ARV) drugs. Though the trial will be small and isn’t seeking to cure the study participants, it could help propel HIV cure research forward.

Experts in the field of virology and immunology haven’t given up on the possibility of a cure for HIV disease, and in recent years they’ve begun to test numerous strategies to flush out the reservoirs of HIV that hide within long-lived cells in the gut, brain and other sanctuary sites. These cells, most of which are in a resting state, are outside the reach of current ARVs—none of which work in resting cells—and the immune system, which has a hard time identifying and killing infected cells when they aren’t in an activated state.

Scientists believe that in order to flush the virus out of resting cells, the cells have to be activated, and research attention is currently focused on finding drugs with the power to do just that. Antabuse is one such drug. It has been in use for years to treat alcoholism—it makes people who drink alcohol become ill. Antabuse is now available as a generic drug, and it has a well-documented safety profile, making it an ideal candidate for testing.

Aside from making people feel terrible when they drink, Antabuse also has the ability to activate immune cells. Whether it can activate latently infected cells and make them vulnerable to HIV treatment and the immune system is not yet known, and that is what the study seeks to understand. In the trial, people will add 400 milligrams of Antabuse once a day to their current ARV regimen for two weeks, and then be followed for six months to look for signs of immune activation.

It is likely that Antabuse would have to be added to other immune-activating drugs in order to achieve a cure. Also, it is not yet known how long a person would have to be on such medications to flush out the reservoir. Nevertheless, if researchers can prove that Antabuse is able to activate latently infected cells, it could go into wider scale testing in combination with other drugs with the goal of achieving eradication.

The trial is currently recruiting volunteers in Baltimore and San Francisco (information on the trial can be found here) and expects to produce data by the summer of 2012.

Search: Antabuse, disulfiram, cellular activation, immune activation, latent cells, HIV reservoir


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (3 total)


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    chrisf
    san jose
    California


    slimcuteguy
    Asheville
    North Carolina


    cortaza100
    Chicago
    Illinois


    HOTROD2010
    houston
    Texas
Click here to join POZ Personals!
Conference Coverage

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


20th Conference on Retroviruses and Opportunistic Infections
(CROI 2013)
Atlanta, GA
March 3 - 7, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.